Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/46988

TitleA semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking
Author(s)Carvalho, M.
Maia, F. Raquel
Silva-Correia, Joana
Costa, Bruno Marques
Reis, R. L.
Oliveira, J. M.
KeywordsCell tracking
Circulating tumor cells
Microfluidics
Nanoparticles
Theranostics
Issue dateFeb-2017
PublisherFuture Medicine Ltd
JournalNanomedicine
CitationCarvalho M., Maia F. R., Silva-Correia J., Costa B. M., Reis R. L., Oliveira J. M. A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking., Nanomedicine, doi:10.2217/nnm-2016-0344, 2017
Abstract(s)Aims: develop a platform composed of labeled dendrimer nanoparticles and a microfluidic device for real-time monitoring of cancer cells fate. Materials and Methods: The physicochemical and biological characterization of the developed Carboxymethyl-chitosan/poly(amidoamine) (CMCht/PAMAM) dendrimer nanoparticles were performed using TEM, AFM, Zeta Sizer, DSC and cytotoxicity screening. Cancer cell lines derived from different tumor types, including HeLa (Cervical Carcinoma), HCT-116 (Colon Carcinoma) and U87MG (Glioblastoma), were exposed to different concentrations of CMCht/PAMAM dendrimer nanoparticles over a period of 3 days (MTS/DNA). Results: Nanoparticles were successfully modified with an average size of 50 nm. Internalization levels go from 87% to 100% in static and from 95% to 100% in dynamic conditions. Viability levels range from 95% to 100% in static and from 90% to 100% in dynamic conditions, being HCT the most sensitive to the presence of the NP. Conclusions: the results show different responses to the presence of 0.5 mg.mL-1 dendrimer nanoparticles when comparing static to dynamic conditions, with a tendency towards higher sensitivity when subjected to confinement. This work demonstrated that the proposed microfluidic-based platform allows real-time cell monitoring, which, upon more studies, namely the assessment of the drug release effect, could be used for cancer theranostics.
TypeArticle
URIhttp://hdl.handle.net/1822/46988
DOI10.2217/nnm-2016-0344
ISSN1743-5889
e-ISSN1748-6963
Publisher versionhttps://www.ncbi.nlm.nih.gov/pubmed/28186438
Peer-Reviewedyes
AccessOpen access
Appears in Collections:3B’s - Artigos em revistas/Papers in scientific journals

Files in This Item:
File Description SizeFormat 
19004-paper nanomedicine.pdf5,04 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID